Abe, Masahiro <br/><br/>
[Myeloma bone disease and RANKL signaling].  [electronic resource] 

 -  Clinical calcium  Aug 2011 
 - 1167-74 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article; Review 
<br/><br/><label>ISSN: </label>0917-5857 
<br/><br/><label>Standard No.: </label>CliCa110811671174  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--physiology<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Bone Resorption--genetics<br/>Cell Differentiation--genetics<br/>Denosumab<br/>Humans<br/>Macrophage Inflammatory Proteins--physiology<br/>Molecular Targeted Therapy<br/>Multiple Myeloma--drug therapy<br/>Osteoblasts--cytology<br/>Osteoclasts--cytology<br/>RANK Ligand--immunology<br/>Repressor Proteins--physiology<br/>Signal Transduction--physiology<br/>Transforming Growth Factor beta--physiology